Clinical Trial Update: Phase IV Study to Evaluate the Efficacy and Safety of Mircera in PD [Phase 4]

View source ↗

Summary

This is a Phase IV clinical trial evaluating the efficacy and safety of Mircera in Parkinson disease. The sponsor is Samsung Medical Center, and the current tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA)

Snippet

Sponsor: Samsung Medical Center | Conditions: PD | Phase 4 | Status: UNKNOWN